Moderna, Inc.

MRNANASDAQHealthcare● Active

$48.27

+$0.83(+1.75%)

Market Cap$19.2B

P/E Ratio—

52W High$59.55

52W Low$22.28

Avg Volume7.0M

Open$48.22

Beta1.03

Overview

Moderna, Inc. (MRNA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MRNA · net income · updated Jun 8, 2026

Core profitability metrics

MRNA · net income · margin · TTM · CAGR

Net income was −$2.82B for FY2025 (fiscal year ending 2025-12-31), up 20.8% year-over-year. Net profit margin was -145.2%. Based on available data, Moderna, Inc. has been profitable since at least 2021.

FY2025 Net Income−$2.82B▲ +20.8% YoY

Trailing 12M (TTM)−$3.19Btrailing 4 quarters sum

Net Profit Margin-145.2%−$2.82B ÷ $1.94B

YoY Change+20.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · MRNA net income history · MRNA profit margin

Annual net income data

MRNA · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$2.82B▲ +20.8%-145.2%$1.94B

FY2024Loss−$3.56B▲ +24.5%-111.3%$3.20B

FY2023Loss−$4.71B▼ 156.4%-68.8%$6.85B

FY2022$8.36B▼ 31.5%44.3%$18.88B

FY2021★ First Profit$12.20B▲ +1733.3%68.8%$17.74B

Net income vs peers (Healthcare)

MRNA vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Moderna, Inc.YOU

MRNA

−$2.82B+20.8%-145.2%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Moderna, Inc. (MRNA) reported net income of −$2.82B for FY2025 (fiscal year ending 2025-12-31), up 20.8% year-over-year. The net profit margin was -145.2% — meaning the company kept $-1.45 of every dollar of revenue as profit.

Based on available data, Moderna, Inc. has been profitable since at least 2021. Net income reached a peak of $12.20B in FY2021. Data available for 10 fiscal years.

Moderna, Inc.'s net profit margin was -145.2% for FY2025, based on the latest annual results.

Investors sometimes search for "Moderna, Inc. net worth" — the company's market capitalization is a separate figure from MRNA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MRNA net income · 4 questions

Moderna, Inc. is not currently profitable on an annual basis. The company reported a net loss of $2.82B for FY2025.

is MRNA profitabledoes MRNA make a profitMRNA profitabilityMRNA profitable company

▸ Source: FMP /income-statement · GAAP · Moderna, Inc. · Moderna, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026